MTOR and central nervous system cancer: In a previous study, we demonstrated that CAMK1D exerts a significant influence on glioma cell invasion through the phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway [20].